APA (7th ed.) Citation

Sun, X., Wu, Y., Xing, R., Bai, X., Qian, J., Zhu, H., . . . Liu, Y. (2022). Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Sun, Xuefei, et al. Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China. Frontiers Media S.A, 2022.

MLA (9th ed.) Citation

Sun, Xuefei, et al. Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China. Frontiers Media S.A, 2022.